BioSig Technologies Inc. Announces Pricing of $15 Million Public Offering

Company Overview - BioSig Technologies, Inc. recently merged with Streamex Exchange Corporation, enhancing its market position in the gold tokenization sector [1][5] - BioSig is a medical device technology company specializing in advanced digital signal processing technology for electrophysiology [6][7] Public Offering Details - The company announced a public offering of 3,852,149 shares of common stock at a price of $3.90 per share, with expected gross proceeds of approximately $15,023,381.10 [1] - The offering is set to close on or around August 15, 2025, subject to customary closing conditions [1] Use of Proceeds - The net proceeds from the offering will be utilized for purchasing gold bullion, working capital, and general corporate purposes [1] Underwriters - Clear Street and Needham & Company are acting as joint book-running managers for the offering [2] Regulatory Compliance - The offering is made under a shelf registration statement declared effective by the SEC on December 17, 2024, with a final prospectus supplement to be filed [3]